The autoimmune disease diagnostics market size surpassed US$ 14.6 Bn in 2019 and to reach US$ 20 billion by 2027 with a CAGR of 3.7% from 2020 to 2027.
Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market. Rising awareness among people and increasing government initiatives are the major factors driving the autoimmune disease diagnostics market.
AARDA initiated the formation of the Center for Autoimmune Disease Research at Johns Hopkins University Medical Center and the NIH established Centers of Excellence in autoimmune diseases. AARDA also sponsors various programs and workshops aimed at bringing together researchers from different disciplines involved in autoimmune research. These factors are likely to fuel the growth of the market.
Overview
- In autoimmune disease body's immune system attacks its own healthy cells. There are at least 80 types of autoimmune diseases. Autoimmune disease diagnostics include various tests such as antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, and urinalysis that aid in the diagnosis of autoimmune diseases
- North America was the largest market for autoimmune disease diagnostics in 2018 due to increased awareness about advanced diagnostic techniques and increasing government initiatives. For instance, the American Autoimmune Related Diseases Association, Inc. (AARDA) and the National Institutes of Health (NIH) initiated different programs for the development and advancement of autoimmune disease treatment and diagnosis in the U.S.
- Asia Pacific is likely to be a highly lucrative market for autoimmune disease diagnostics and it is expected to expand at a high CAGR during the forecast period. Adoption of new and sophisticated technologies, advances in diagnostic technologies, and increasing partnership of governments with private players and clinical laboratories are likely to propel the growth of market during the forecast period. For instance, India-based SRL Diagnostics partnered with state governments to set up and operate 24 labs in large state-run hospitals in various districts.
Growing Awareness among People about Autoimmune Diseases and High Prevalence of Autoimmune Diseases across the World to Drive Market
- Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market. Furthermore, governments across countries are taking various initiatives and organizing programs in order to create awareness among the people about autoimmune diseases. For instance, the American Autoimmune Related Diseases Association, Inc. (AARDA) and the National Institutes of Health (NIH) initiated various programs for the development and advancement of autoimmune disease treatment and diagnosis in the U.S.
- Rising prevalence of autoimmune diseases is likely to fuel the growth of the autoimmune disease diagnostics market. Therefore, consistent increase in the autoimmune patient population across the world has been identified as one of the major factors driving the autoimmune disease diagnostics market.
Autoantibody Test Segment to Dominate Market
- Based on test type, the global autoimmune disease diagnostics market has been divided into antinuclear antibody test, autoantibody test, complete blood count (CBC), comprehensive metabolic panel, c-reactive protein (CRP) test, erythrocyte sedimentation rate (ESR), urinalysis and others.
- Autoantibody test segment dominated the global autoimmune disease diagnostics market in 2018 and the trend is projected to continue during the forecast period. Autoantibody tests are performed when a patient is suffering from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. Initially, antinuclear antibody (ANA) test is performed (a primary test to evaluate a person for autoimmune disorders) and is frequently followed up with other specific autoantibody tests such as anti-Sjögren’s syndrome A (anti-SSA/Ro), anti-double strand DNA (anti-dsDNA), anti-Sjögren’s syndrome B (anti-SSB/La), and anti-ribonucleic protein (anti-RNP), etc.
- An article published by the American Association for Clinical Chemistry, stated that over 32 million people in the U.S. have autoantibodies, with antinuclear antibody the most prevalent and common type of antibodies present among women, older individuals, and African-Americans
Rheumatoid Arthritis to be Highly Lucrative Segment
- In terms of disease type, the global autoimmune disease diagnostics market has been classified into Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and others.
- Rheumatoid Arthritis segment dominated the autoimmune disease diagnostics market as well as growing with the highest CAGR in the forecast period due to rising prevalence of diseases, increase in global health care expenditure and growing public awareness about autoimmune diseases. The annual incidence of Rheumatoid Arthritis in the U.S. and northern European countries is estimated to be approximately 40 per 100,000 persons.
- RA is diagnosed based on the result of joint X-rays and a rheumatoid factor (RF). The baseline laboratory evaluation includes complete blood count (CBC) with differential, erythrocyte sedimentation rate (ESR), and C-reactive protein tests.
North America to Dominate Global Market
- In terms of region, the global autoimmune disease diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global autoimmune disease diagnostics market in 2018, followed by Europe. The dominance of these two regions can be attributed to increasing prevalence of autoimmune diseases, rising awareness among people about advanced laboratory tests, and growing health care expenditure.
- North America accounted for major share of the global autoimmune disease diagnostics market in 2018, primarily due to high awareness about procedures and advanced laboratory techniques, increase in patient pool, and high health care expenditure. American Autoimmune Related Diseases Association, Inc. (AARDA) initiated the formation of the Center for Autoimmune Disease Research at Johns Hopkins University Medical Center and NIH established Centers of Excellence in autoimmune diseases.
- Emerging markets in Asia Pacific holds immense growth potential due to factors such as rise in the prevalence of autoimmune diseases, increase in the geriatric population, increasing government initiatives, and rise in health care infrastructure
Competitive Landscape
- The global autoimmune disease diagnostics market is fragmented in terms of number of players. Key players in the global market include Abbott Laboratories, Inc., Beckman Coulter, Inc. , bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics, Inc., Quest Diagnostics, SQI Diagnostics, Inc., Siemens Healthcare among others
The global autoimmune disease diagnostics market has been segmented as follows:
By Test Type
-
- Antinuclear Antibody Test
- Autoantibody Test
- Complete Blood Count (CBC)
- Comprehensive Metabolic Panel
- C-reactive Protein (CRP) Test
- Erythrocyte Sedimentation Rate (ESR)
- Urinalysis
- Others
By Disease Type
-
- Graves’ Disease
- Hashimoto’s Thyroiditis
- Multiple Sclerosis
- Rheumatoid Arthritis
- SLE (Lupus)
- Type 1 Diabetes
- Others
By Region
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Scope of Report
VRR’s report on the global autoimmune disease diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global autoimmune disease diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global autoimmune disease diagnostics market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global autoimmune disease diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global autoimmune disease diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global autoimmune disease diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global autoimmune disease diagnostics market.
The report delves into the competitive landscape of the global autoimmune disease diagnostics market. Key players operating in the global autoimmune disease diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global autoimmune disease diagnostics market that have been profiled in this report.
Key Questions Answered in Global Autoimmune Disease Diagnostics Market Report
- What is the scope of growth of product companies in the global autoimmune disease diagnostics market?
- What will be the Y-o-Y growth of the global autoimmune disease diagnostics market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global autoimmune disease diagnostics market?
- Will North America continue to be the most profitable market for autoimmune disease diagnostics devices providers?
- Which factors are anticipated to hamper the growth of the global autoimmune disease diagnostics market during the forecast period?
- Which are the leading companies in the global autoimmune disease diagnostics market?
Research Methodology
A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global autoimmune disease diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global autoimmune disease diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the autoimmune disease diagnostics market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the autoimmune disease diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global autoimmune disease diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global autoimmune disease diagnostics market more reliably and accurately.
Cross-segment Market Size and Analysis for
Mentioned Segments
